Continuous and intermittent levamisole. A controlled trial.
A double-blind comparative trial showed that intermittent levamisole therapy (150 mg daily for 3 days of each week) was as effective as continuous therapy (150 mg daily) in rheumatoid arthritis and with slightly fewer side effects.
D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004334:Drug Administration Schedule; D006801:Humans; D007978:Levamisole / Q000008:administration & dosage* / Q000627:therapeutic use; D013997:Time Factors
D007978:Levamisole